| Q89892713 | A C-terminal peptide from type I interferon protects the retina in a mouse model of autoimmune uveitis |
| Q33919012 | A balancing act: RNA binding protein HuR/TTP axis in endometriosis patients |
| Q39678770 | A combination of hypoxia and lipopolysaccharide activates tristetraprolin to destabilize proinflammatory mRNAs such as tumor necrosis factor-alpha |
| Q24315797 | A computational study of RNA binding and specificity in the tandem zinc finger domain of TIS11d |
| Q36979267 | A molecular mechanism for TNF-α-mediated downregulation of B cell responses |
| Q24535929 | AU-rich elements and associated factors: are there unifying principles? |
| Q42109733 | Altered CD38/Cyclic ADP-Ribose Signaling Contributes to the Asthmatic Phenotype |
| Q36072305 | Altered CELF1 binding to target transcripts in malignant T cells |
| Q34014654 | An enigmatic tail of CD28 signaling |
| Q34045755 | Analysis of CUGBP1 targets identifies GU-repeat sequences that mediate rapid mRNA decay |
| Q28589341 | Brf1 posttranscriptionally regulates pluripotency and differentiation responses downstream of Erk MAP kinase |
| Q89748211 | CFIm25-regulated lncRNA acv3UTR promotes gastric tumorigenesis via miR-590-5p/YAP1 axis |
| Q39669203 | Cerebral preconditioning using cortical application of hypertonic salt solutions: upregulation of mRNAs encoding inhibitors of inflammation |
| Q36623382 | Chapter 4. Evaluating the control of mRNA decay in fission yeast |
| Q37329960 | Characterization of zfs1 as an mRNA-binding and -destabilizing protein in Schizosaccharomyces pombe |
| Q24646793 | Conserved GU-rich elements mediate mRNA decay by binding to CUG-binding protein 1 |
| Q35086885 | Control of mRNA stability by SAPKs. |
| Q24626214 | Coordinate regulation of mRNA decay networks by GU-rich elements and CELF1 |
| Q35044265 | Deletion of tristetraprolin caused spontaneous reactive granulopoiesis by a non-cell-autonomous mechanism without disturbing long-term hematopoietic stem cell quiescence |
| Q40152805 | Down-regulation of tristetraprolin expression results in enhanced IL-12 and MIP-2 production and reduced MIP-3alpha synthesis in activated macrophages. |
| Q34200816 | Downregulation of the AU-rich RNA-binding protein ZFP36 in chronic HBV patients: implications for anti-inflammatory therapy |
| Q90701023 | Effects of interleukin-2 in immunostimulation and immunosuppression |
| Q37963286 | Evaluating posttranscriptional regulation of cytokine genes |
| Q40107982 | FRET-detectable interactions between the ARE binding proteins, HuR and p37AUF1. |
| Q26773059 | Feedback Regulation of Kinase Signaling Pathways by AREs and GREs |
| Q39984664 | Gene expression studies reveal that DNA damage, vascular perturbation, and inflammation contribute to the pathogenesis of carbonyl sulfide neurotoxicity |
| Q36727319 | Genome-wide analysis identifies interleukin-10 mRNA as target of tristetraprolin |
| Q35131624 | Glucocorticoids regulate tristetraprolin synthesis and posttranscriptionally regulate tumor necrosis factor alpha inflammatory signaling. |
| Q37138745 | High-concentrate feeding upregulates the expression of inflammation-related genes in the ruminal epithelium of dairy cattle |
| Q35210986 | Hypoxia-inducible factor-1α mRNA: a new target for destabilization by tristetraprolin in endothelial cells |
| Q38292350 | Identification of TTP mRNA targets in human dendritic cells reveals TTP as a critical regulator of dendritic cell maturation |
| Q47433840 | Inflammation-regulated mRNA stability and the progression of vascular inflammatory diseases. |
| Q37560020 | Inflammation: cytokines and RNA-based regulation |
| Q34767912 | Insulin increases tristetraprolin and decreases VEGF gene expression in mouse 3T3-L1 adipocytes |
| Q28588817 | MCPIP1 down-regulates IL-2 expression through an ARE-independent pathway |
| Q53381894 | Modulation and the Underlying Mechanism of T Cells in Thymus of Mice by Oral Administration of Sodium Fluoride. |
| Q84767795 | Molecular identification of the gene encoding porcine tristetraprolin (TTP) |
| Q37428698 | Mutational and structural analysis of the tandem zinc finger domain of tristetraprolin |
| Q36229317 | NF90 regulates inducible IL-2 gene expression in T cells |
| Q37940393 | Networks controlling mRNA decay in the immune system. |
| Q51740585 | Neuroprotective Effect of Protein Phosphatase 2A/Tristetraprolin Following Subarachnoid Hemorrhage in Rats. |
| Q24338694 | Not1 mediates recruitment of the deadenylase Caf1 to mRNAs targeted for degradation by tristetraprolin |
| Q35221409 | Novel mRNA targets for tristetraprolin (TTP) identified by global analysis of stabilized transcripts in TTP-deficient fibroblasts |
| Q35516227 | Novel phosphorylation-dependent ubiquitination of tristetraprolin by mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 1 (MEKK1) and tumor necrosis factor receptor-associated factor 2 (TRAF2). |
| Q34065505 | Osmotic stress regulates mineralocorticoid receptor expression in a novel aldosterone-sensitive cortical collecting duct cell line. |
| Q34485096 | Phosphorylation of Tristetraprolin by MK2 Impairs AU-Rich Element mRNA Decay by Preventing Deadenylase Recruitment |
| Q28115076 | Phosphorylation of human tristetraprolin in response to its interaction with the Cbl interacting protein CIN85 |
| Q33309340 | Phosphorylation site analysis of the anti-inflammatory and mRNA-destabilizing protein tristetraprolin |
| Q37113415 | Post-transcriptional control of cytokine production |
| Q38238033 | Post-transcriptional gene regulation by RNA-binding proteins in vascular endothelial dysfunction |
| Q33893392 | Post-transcriptional regulation in lymphocytes: the case of CD154 |
| Q39036700 | Post-transcriptional regulation of cytokine and growth factor signaling in cancer |
| Q38095507 | Post-transcriptional regulatory networks in immunity. |
| Q37661362 | Post-transcriptional regulons coordinate the initiation and resolution of inflammation |
| Q38125686 | Posttranscriptional Gene Regulation: Novel Pathways for Glucocorticoids' Anti-inflammatory Action |
| Q47601835 | Posttranscriptional control of airway inflammation |
| Q36472030 | Posttranscriptional mechanisms regulating the inflammatory response. |
| Q24319752 | Posttranscriptional modulation of cytokine production in T cells for the regulation of excessive inflammation by TFL |
| Q37153447 | Posttranscriptional regulation of IL-13 in T cells: role of the RNA-binding protein HuR. |
| Q37557530 | Posttranscriptional regulation of IL-23 expression by IFN-gamma through tristetraprolin |
| Q35221436 | Probing the structural and dynamical effects of the charged residues of the TZF domain of TIS11d |
| Q37172253 | Production and characterization of ZFP36L1 antiserum against recombinant protein from Escherichia coli. |
| Q36784690 | Proteasome inhibitor PS-341 (VELCADE) induces stabilization of the TRAIL receptor DR5 mRNA through the 3'-untranslated region |
| Q33748220 | Pterostilbene 4'-β-Glucoside Protects against DSS-Induced Colitis via Induction of Tristetraprolin. |
| Q37188171 | Quantitative evaluation of His-tag purification and immunoprecipitation of tristetraprolin and its mutant proteins from transfected human cells. |
| Q89146094 | RNA Degradation in Neurodegenerative Disease |
| Q97521645 | RNA-Binding Protein ZFP36L2 Downregulates Helios Expression and Suppresses the Function of Regulatory T Cells |
| Q26866134 | RNA-binding proteins and gene regulation in myogenesis |
| Q30434431 | RNA-destabilizing factor tristetraprolin negatively regulates NF-kappaB signaling |
| Q36776927 | Rapid transit in the immune cells: the role of mRNA turnover regulation. |
| Q35668767 | Regulation of CUG-binding protein 1 (CUGBP1) binding to target transcripts upon T cell activation |
| Q39215435 | Regulation of mRNA stability by CCCH-type zinc-finger proteins in immune cells |
| Q54480140 | Regulation of tristetraprolin expression by mitogen-activated protein kinase phosphatase-1. |
| Q38791244 | Resolution of inflammation: a new therapeutic frontier |
| Q37617262 | Role of 3'-untranslated region translational control in cancer development, diagnostics and treatment |
| Q36826366 | Role of the RNA-binding protein tristetraprolin in glucocorticoid-mediated gene regulation. |
| Q37145349 | Stimulation of polo-like kinase 3 mRNA decay by tristetraprolin |
| Q42172454 | Structural Basis of the Disorder in the Tandem Zinc Finger Domain of the RNA-Binding Protein Tristetraprolin. |
| Q37210848 | Suppression of IL-12 production by tristetraprolin through blocking NF-kcyB nuclear translocation |
| Q40141296 | Syk-dependent ERK activation regulates IL-2 and IL-10 production by DC stimulated with zymosan |
| Q37292351 | TIS11 family proteins and their roles in posttranscriptional gene regulation |
| Q28585888 | Targeted disruption of Zfp36l2, encoding a CCCH tandem zinc finger RNA-binding protein, results in defective hematopoiesis |
| Q90070036 | The RNA-Binding Protein KSRP Modulates Cytokine Expression of CD4+ T Cells |
| Q87600987 | The abnormal expressions of tristetraprolin and the VEGF family in uraemic rats with peritoneal dialysis |
| Q37518110 | The cAMP pathway regulates mRNA decay through phosphorylation of the RNA-binding protein TIS11b/BRF1. |
| Q47547598 | The hepatitis C viral nonstructural protein 5A stabilizes growth-regulatory human transcripts |
| Q33627886 | The mRNA decay factor tristetraprolin (TTP) induces senescence in human papillomavirus-transformed cervical cancer cells by targeting E6-AP ubiquitin ligase |
| Q28243779 | The p38 MAPK pathway inhibits tristetraprolin-directed decay of interleukin-10 and pro-inflammatory mediator mRNAs in murine macrophages |
| Q35128284 | The role of HuR in the post-transcriptional regulation of interleukin-3 in T cells. |
| Q36290434 | The role of tristetraprolin in cancer and inflammation |
| Q24633013 | The roles of TTP and BRF proteins in regulated mRNA decay |
| Q33588805 | Tissue- and age-dependent expression of RNA-binding proteins that influence mRNA turnover and translation |
| Q38589466 | Translating the Untranslated Region. |
| Q37119721 | Tristetraprolin (TTP): interactions with mRNA and proteins, and current thoughts on mechanisms of action |
| Q99404874 | Tristetraprolin Regulates TH17 Cell Function and Ameliorates DSS-Induced Colitis in Mice |
| Q41918691 | Tristetraprolin inhibits macrophage IL-27-induced activation of antitumour cytotoxic T cell responses |
| Q35107415 | Tristetraprolin mediates anti-inflammatory effects of nicotine in lipopolysaccharide-stimulated macrophages |
| Q37160867 | Tristetraprolin mediates interferon-gamma mRNA decay |
| Q50336105 | Tristetraprolin recruits functional mRNA decay complexes to ARE sequences |
| Q37125741 | Tristetraprolin regulation of interleukin 23 mRNA stability prevents a spontaneous inflammatory disease |
| Q36184781 | Tristetraprolin regulation of interleukin-22 production |
| Q64069952 | Tristetraprolin specifically regulates the expression and alternative splicing of immune response genes in HeLa cells |
| Q37080841 | Tristetraprolin-driven regulatory circuit controls quality and timing of mRNA decay in inflammation |
| Q37392111 | Two pathways of costimulation through CD28. |
| Q55256636 | Uncovering the Role of RNA-Binding Proteins in Gene Expression in the Immune System. |
| Q55434576 | ZFP36 RNA-binding proteins restrain T cell activation and anti-viral immunity. |
| Q39356710 | ZFP36 expression impairs glioblastoma cell lines viability and invasiveness by targeting multiple signal transduction pathways |
| Q28119162 | ZFP36L1 negatively regulates erythroid differentiation of CD34+ hematopoietic stem cells by interfering with the Stat5b pathway |
| Q34533271 | ZFP36L1 negatively regulates plasmacytoid differentiation of BCL1 cells by targeting BLIMP1 mRNA. |
| Q36114612 | cAMP stimulation of StAR expression and cholesterol metabolism is modulated by co-expression of labile suppressors of transcription and mRNA turnover |
| Q28118974 | cAMP-dependent posttranscriptional regulation of steroidogenic acute regulatory (STAR) protein by the zinc finger protein ZFP36L1/TIS11b |